๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Suppression and transient induction of lymphokines in cancer patients after administration of polyethylene glycolated interleukin-2

โœ Scribed by Yihshing Shih; Michael W. Konrad; M. Kim Warren; Anne Childs; Carolyn Paradise; Frederick J. Meyers; Eric S. Groves

Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
781 KB
Volume
22
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Trends in the safety of high dose bolus
Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer
โœ Udai S. Kammula; Donald E. White; Steven A. Rosenberg ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 130 KB ๐Ÿ‘ 2 views

## BACKGROUND. Administration of recombinant high dose interleukin-2 (IL-2) can mediate tumor regression in patients with metastatic melanoma and renal carcinoma. Significant trends in the safety of high dose IL-2 administration at a single institution over a 12-year study period were reviewed. #

In vitro anti-tumor activity of eosinoph
In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5
โœ Licia Rivoltini; Mario Paolo Colombo; Giorgio Parmiani; Vincenzo Viggiano; Silvi ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 1004 KB

lnterleukin 2 (IL-2) administration is known to induce marked eosinophilia. To evaluate the potential role of eosinophils as anti-tumor effectors and t o understand the direct or indirect effects of IL-2 on eosinophils, the physical and functional characteristics of eosinophils obtained during IL-2